136 related articles for article (PubMed ID: 31973613)
1. Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis.
Fang J; Xu X; Mao Q; Ying Y; Zhang X; Xie L
Int J Biol Markers; 2020 Mar; 35(1):57-64. PubMed ID: 31973613
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
3. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
[TBL] [Abstract][Full Text] [Related]
4. Low adiponectin levels are associated with renal cell carcinoma: a case-control study.
Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS;
Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522
[TBL] [Abstract][Full Text] [Related]
5. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials.
Liu X; Zhang W; Zhao M; Jia G; Sun R
Lipids Health Dis; 2019 Dec; 18(1):228. PubMed ID: 31870381
[TBL] [Abstract][Full Text] [Related]
8. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis.
Ye J; Jia J; Dong S; Zhang C; Yu S; Li L; Mao C; Wang D; Chen J; Yuan G
Eur J Cancer Prev; 2014 May; 23(3):158-65. PubMed ID: 23929213
[TBL] [Abstract][Full Text] [Related]
9. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma.
Xu XT; Xu Q; Tong JL; Zhu MM; Huang ML; Ran ZH; Xiao SD
J Dig Dis; 2011 Aug; 12(4):234-44. PubMed ID: 21791018
[TBL] [Abstract][Full Text] [Related]
11. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study.
Spyridopoulos TN; Petridou ET; Dessypris N; Terzidis A; Skalkidou A; Deliveliotis C; Chrousos GP;
Hormones (Athens); 2009; 8(1):39-46. PubMed ID: 19278051
[TBL] [Abstract][Full Text] [Related]
12. Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies.
Zhang Y; Zhang DZ
Int J Food Sci Nutr; 2018 Dec; 69(8):1003-1012. PubMed ID: 29513118
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
16. Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis.
Yoon YS; Kwon AR; Lee YK; Oh SW
Obes Res Clin Pract; 2019; 13(4):329-339. PubMed ID: 31003933
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels in relation to carotid atherosclerotic plaque presence, ischemic stroke risk, and mortality: A systematic review and meta-analyses.
Gorgui J; Gasbarrino K; Georgakis MK; Karalexi MA; Nauche B; Petridou ET; Daskalopoulou SS
Metabolism; 2017 Apr; 69():51-66. PubMed ID: 28285652
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies.
Gong TT; Wu QJ; Wang YL; Ma XX
Int J Cancer; 2015 Oct; 137(8):1967-78. PubMed ID: 25899043
[TBL] [Abstract][Full Text] [Related]
19. Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials.
Shu X; Chi L
Drug Des Devel Ther; 2019; 13():1633-1641. PubMed ID: 31190742
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Zigeuner R
Eur Urol; 2008 Oct; 54(4):873-4. PubMed ID: 18343563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
